Bluebird Bio: Gene Therapy Launches Could Bring Big Revenues (NASDAQ:BLUE)
Bluebird bio is a major player in gene therapy for haemoglobinopathies Shutter2U/iStock via Getty Images Bluebird Bio (BLUE) is a biotech company specialising in lentiviral vector gene therapies for genetic blood disorders. Its portfolio offers […]
